# Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

> **NCT06135363** · PHASE1 · COMPLETED · sponsor: **Guangzhou JOYO Pharma Co., Ltd** · enrollment: 45 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** SC1011
- **DRUG:** Placebo tablet

## Key facts

- **NCT ID:** NCT06135363
- **Lead sponsor:** Guangzhou JOYO Pharma Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-11
- **Primary completion:** 2023-01-14
- **Final completion:** 2023-01-14
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06135363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06135363, "Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06135363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*